The Market of Safed Musli
largest global markets of Safed Musli are China,
France, Germany, Italy, Japan, Spain, UK and USA.
Japan has the highest per capita consumption of botanical
medicines in the world. In the US and Europe, the trade
has typically been growing at an average of 10 per cent
per annum, partly because of the popularity of alternative
treatments and partly because there is increasing official
recognition of the benefits of traditional medical systems
involving herbal preparations. The International Council
for Medicinal and Aromatic Plants expects world growth
during 2001 and 2002 to be approximately 8-10 per cent
a year. The US has recently been an exception, with
a sharp drop in sales. In 1997, the five top-selling
species in the US were Echinacea, Garlic, Ginkgo, Golden
seal and Saw palmetto. In 1999, the world market for
herbal remedies was US$19.4 billion, with Europe in
the lead (US$6.7 billion), followed by Asia (US$5.1
billion), North America (US$4.0 billion), Japan (US$2.2
billion) and the rest of the world (US$1.4 billion).
The market in China is large and shared between public
and private ownership. Thirteen of the top companies
producing Traditional Chinese Medicines (TCMs) are listed
publicly on the domestic stock exchange. Fourteen are
state-owned. China’s total output of medicinal
plants from both cultivated and wild-harvested sources
is 1.6 million tonnes. The total value of the finished
TCM sector in 1996 was US$3.7 billion. This estimate
excludes domestic consumption, the inclusion of which
would result in a far higher figure. Overall sales of
botanical medicine products in China in 1995 were estimated
at US$5 billion. The botanical medicine market in Japan
in 1996 was estimated at US$2.4 billion.
has the highest per capita consumption of botanical
medicines in the world, and sales have grown rapidly
in recent years, in part because doctors increasingly
incorporate TCM as a complement to western medicine.
In 1983, 28 per cent of doctors used TCM, but by 1989
this figure had risen to 69 per cent.
India is a major exporter of raw MAPs and processed
plant-based drugs. Exports of crude drugs from India
in 1994-95 were valued at US$53,219 million and of essential
oils US$13,250 million. Important crude drugs included
Plantago ovata (psyllium), Panax spp. (ginseng), Cassia
spp. (senna) and Catharanthus roseus (rosy periwinkle).
Essential oils included Santalum album (sandalwood),
Mentha arvensis (peppermint) and Cymbopogon flexuosus
(lemongrass). Seventy-five per cent of total exports
from India are sent to six countries – France,
Germany, Japan, Switzerland, UK and USA. Other major
importers are Bangladesh, Pakistan and Spain.
The Demand of Safed Musli
Ayurvedic literature, Safed Musli is renowned as Divya
Aushad with enormous importance in the preparation
of over one hundred different medicines. There is no
gainsaying the fact that Safed Musli is an inevitable
ingredient in any immunity-strengthening drugs. By virtue
of being the home of Ayurveda, India has naturally been
a huge market for Safed Musli. Also in western India,
especially in Gujarat, people are given to the habit
of taking a spoon of Safed Musli along with milk twice
a day as a part of routine health-care. There are also
instances of Safed Musli being used in various ways
in varied parts of the country. That underlines the
reason for a great deal of demand for Safed Musli in
Many countries in the Gulf, Europe including USA have
been major importers of the dry roots of Safed Musli
for a very long time, for its use in the making of various
herbal products and thinks to the increasing awareness
and appreciation of the goodness of herbal products.
The demand for Safed Musli has been phenomenally growing
across the globe.